Has the Right B-cell Depleting Drug Been Found for ME/CFS? Daratumumab Shines in Pilot Study
A B-cell depleter called daratumumab does well in an early trial in ME/CFS. A larger trial is underway.
Stymied, Moving Forward or Both? The Long-COVID (and ME/CFS) Clinical Trials Dilemma
Big pharma is largely staying clear of long COVID trials but the many small and some quite large clinical trials are underway provide hope.
“What’s Up, Doc?” Nancy Klimas on Viruses, ME/CFS’s Greatest Need, and Her ME/CFS Clinical Trial
Dr. Nancy Klimas says what's exciting her most right now in the ME/CFS field is a renewed focus on herpesvirus reactivation and what artificial intelligence will bring.
Three Severely Ill Long COVID Patients – Three Rapid Recoveries: Monoclonal Antibodies, LC and ME/CFS
Three case reports indicate that monoclonal antibody therapy rapidly restored severely ill patients with long term cases of long COVID to health. Implications for chronic fatigue syndrome are explored.StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
